Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide for cognitive improvement in children and adolescents with Down syndrome
2015-005780-16Phase 2Active
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of bumetanide in Down syndrome (2 arms), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoint: Clinical improvement in visual-spatial episodic memory. Started Aug 2016; status: active.
02
Drugs
bumetanide
03
Conditions
Down syndrome
Beyond the preview
Go deeper on 2015-005780-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005780-16.